Distal Versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention: Design and Rationale of the DIPRA Trial.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
02 2022
Historique:
received: 24 01 2021
revised: 04 04 2021
accepted: 05 04 2021
pubmed: 1 5 2021
medline: 26 3 2022
entrez: 30 4 2021
Statut: ppublish

Résumé

Radial artery (RA) catheterization is the access of choice over femoral artery access for most interventional vascular procedures given its safety and faster patient recovery. There has been growing interest in distal radial artery (dRA) access as an alternative to the conventional proximal radial artery (pRA) access. Preserving the RA is important which serves as a potential conduit for future coronary artery bypass surgery, dialysis conduit or preserve the artery for future cardiovascular procedures. The dRA runs in close proximity to the radial nerve, which raises the concern of potential detrimental effects on hand function. The Distal versus Proximal Radial Artery Access for cardiac catheterization and intervention (DIPRA) trial is a prospective, randomized, parallel-controlled, open-label, single center study evaluating the outcomes of hand function and effectiveness of dRA compared to pRA access in patients undergoing cardiac catheterization. The eligible subjects will be randomized to dRA and pRA access in a (1:1) fashion. The primary end point is an evaluation of hand function at one and twelve months follow-up. Secondary end points include rates of access site hematoma, access site bleeding, other vascular access complications, arterial access success rate, and RA occlusion at one and twelve months follow up. Effects of dRA on hand function remains unknown and it's use questionable in the presence of a widely accepted pRA. DIPRA trial is designed to determine the safety and effectiveness of dRA for diagnostic and interventional cardiovascular procedures compared to the standard of care pRA.

Sections du résumé

BACKGROUND
Radial artery (RA) catheterization is the access of choice over femoral artery access for most interventional vascular procedures given its safety and faster patient recovery. There has been growing interest in distal radial artery (dRA) access as an alternative to the conventional proximal radial artery (pRA) access. Preserving the RA is important which serves as a potential conduit for future coronary artery bypass surgery, dialysis conduit or preserve the artery for future cardiovascular procedures. The dRA runs in close proximity to the radial nerve, which raises the concern of potential detrimental effects on hand function.
STUDY DESIGN
The Distal versus Proximal Radial Artery Access for cardiac catheterization and intervention (DIPRA) trial is a prospective, randomized, parallel-controlled, open-label, single center study evaluating the outcomes of hand function and effectiveness of dRA compared to pRA access in patients undergoing cardiac catheterization. The eligible subjects will be randomized to dRA and pRA access in a (1:1) fashion. The primary end point is an evaluation of hand function at one and twelve months follow-up. Secondary end points include rates of access site hematoma, access site bleeding, other vascular access complications, arterial access success rate, and RA occlusion at one and twelve months follow up.
CONCLUSION
Effects of dRA on hand function remains unknown and it's use questionable in the presence of a widely accepted pRA. DIPRA trial is designed to determine the safety and effectiveness of dRA for diagnostic and interventional cardiovascular procedures compared to the standard of care pRA.

Identifiants

pubmed: 33926835
pii: S1553-8389(21)00189-5
doi: 10.1016/j.carrev.2021.04.001
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-109

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Karim M Al-Azizi (KM)

Interventional Cardiology and Structural Heart Disease, Texas A&M University College of Medicine, The Heart Hospital - Plano, Baylor Scott & White Health, 1100 Allied Dr, Plano, TX 75093, United States of America. Electronic address: karim.alazizi@bswhealth.org.

Amr Idris (A)

The Heart Hospital Plano - Baylor Scott & White, United States of America.

Jared Christensen (J)

The Heart Hospital Plano - Baylor Scott & White, United States of America.

Mohanad Hamandi (M)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Sarah Hale (S)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Katalin Martits-Chalangari (K)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Johanna S Van Zyl (JS)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Preethi Ravindranathan (P)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Jasjit K Banwait (JK)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Julie Mcckracken (J)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Adam Smith (A)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Ginika Apakama (G)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Jennifer Swim (J)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Penni Dolton (P)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Kristen Chionh (K)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Michael Dimaio (M)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Sibi Thomas (S)

Interventional Cardiology and Structural Heart Disease, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.

Molly Szerlip (M)

Interventional Cardiology and Structural Heart Disease, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.

Sameh Sayfo (S)

Interventional Cardiology and Structural Heart Disease, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.

Chadi Dib (C)

Interventional Cardiology, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.

Michael Mack (M)

Baylor Research Institute, The Heart Hospital Plano - Baylor Scott & White, United States of America.

Srinivasa Potluri (S)

Interventional Cardiology and Structural Heart Disease, The Heart Hospital - Plano, Baylor Scott & White Health, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH